VanEck Pharmaceutical ETF
42 hedge funds and large institutions have $41M invested in VanEck Pharmaceutical ETF in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
45% less capital invested
Capital invested by funds: $74.3M → $41M (-$33.3M)
Holders
42
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.68M | |
| 2 | +$899K | |
| 3 | +$511K | |
| 4 |
SB
Suntrust Banks
Atlanta,
Georgia
|
+$168K |
| 5 |
LPL Financial
San Diego,
California
|
+$119K |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$12.6M | |
| 3 | -$3.19M | |
| 4 |
PI
Placemark Investments
Chicago,
Illinois
|
-$2.08M |
| 5 |
MIM
Macroview Investment Management
Bethesda,
Maryland
|
-$1.81M |